Exact Mass: 333.18471366800003

Exact Mass Matches: 333.18471366800003

Found 79 metabolites which its exact mass value is equals to given mass value 333.18471366800003, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

4-Hydroxyoctanedioylcarnitine

3-[(7-Carboxy-4-hydroxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoic acid

C15H27NO7 (333.1787432)


4-hydroxyoctanedioylcarnitine is an acylcarnitine. More specifically, it is an 4-hydroxyoctanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-hydroxyoctanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-hydroxyoctanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

3-Hydroxyoctanedioylcarnitine

3-[(7-carboxy-3-hydroxyheptanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H27NO7 (333.1787432)


3-hydroxyoctanedioylcarnitine is an acylcarnitine. More specifically, it is an 3-hydroxyoctanedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-hydroxyoctanedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyoctanedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-(2-Hydroxyethoxy)-6-oxohexanoylcarnitine

3-{[6-(2-hydroxyethoxy)-6-oxohexanoyl]oxy}-4-(trimethylazaniumyl)butanoate

C15H27NO7 (333.1787432)


6-(2-hydroxyethoxy)-6-oxohexanoylcarnitine is an acylcarnitine. More specifically, it is an 6-(2-hydroxyethoxy)-6-oxohexanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-(2-hydroxyethoxy)-6-oxohexanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-(2-hydroxyethoxy)-6-oxohexanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Nolomirole

6-(Methylamino)-2-[(2-methylpropanoyl)oxy]-5,6,7,8-tetrahydronaphthalen-1-yl 2-methylpropanoic acid

C19H27NO4 (333.1939982)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

   
   
   

4-(3,4-dimethoxyphenyl)-4-<2-(acetylmethyloamino)ethyl>cyclohexanone

4-(3,4-dimethoxyphenyl)-4-<2-(acetylmethyloamino)ethyl>cyclohexanone

C19H27NO4 (333.1939982)


   
   
   

N-[trans-4-(2-hydroxy-1-methylethyl)cyclohexanecarbonyl]-D-phenylalanine

N-[trans-4-(2-hydroxy-1-methylethyl)cyclohexanecarbonyl]-D-phenylalanine

C19H27NO4 (333.1939982)


   

(-)-alpha-roemehybrine

(-)-alpha-roemehybrine

C19H27NO4 (333.1939982)


   

3,4-Dimethoxy-benzoic acid 8-isopropyl-8-aza-bicyclo[3.2.1]oct-3-yl ester

3,4-Dimethoxy-benzoic acid 8-isopropyl-8-aza-bicyclo[3.2.1]oct-3-yl ester

C19H27NO4 (333.1939982)


   

N-[trans-4-(1-hydroxy-1-methylethyl)cyclohexanecarbonyl]-D-phenylalanine

N-[trans-4-(1-hydroxy-1-methylethyl)cyclohexanecarbonyl]-D-phenylalanine

C19H27NO4 (333.1939982)


   
   

acetyllycoposerramine-U

acetyllycoposerramine-U

C19H27NO4 (333.1939982)


   

7-hydroxyl benzastatin D

7-hydroxyl benzastatin D

C19H27NO4 (333.1939982)


   

2,3,5,6-Tetrahydro,Me ether-4-[2-(Acetylmethylamino)ethyl]-4-(4-hydroxy-3-methoxyphenyl)-2,4-cyclohexadien-1-one

2,3,5,6-Tetrahydro,Me ether-4-[2-(Acetylmethylamino)ethyl]-4-(4-hydroxy-3-methoxyphenyl)-2,4-cyclohexadien-1-one

C19H27NO4 (333.1939982)


   

(2R)-2-[N-(trans-4-isopropylcyclohexylcarbonyl)amino]-3-(4-hydroxyphenyl)-propionic acid

(2R)-2-[N-(trans-4-isopropylcyclohexylcarbonyl)amino]-3-(4-hydroxyphenyl)-propionic acid

C19H27NO4 (333.1939982)


   
   
   
   
   
   
   
   
   
   
   
   
   
   

Hydroxytetrabenazine

Hydroxytetrabenazine

C19H27NO4 (333.1939982)


   

NA 19:6;O3

N-(8-methyl-nonanoyl)-2,3-(Z)-dehydrotyrosine

C19H27NO4 (333.1939982)


   

Drotebanol

Oxymethebanol

C19H27NO4 (333.1939982)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002491 - Central Nervous System Agents > D000700 - Analgesics

   

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-ISOPROPYLPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-ISOPROPYLPHENYL)PYRROLIDINE-3-CARBOXYLIC ACID

C19H27NO4 (333.1939982)


   

2-acetamido-n-(e-aminocaproyl)-2-deoxy-beta-d-glucopyranosylamine

2-acetamido-n-(e-aminocaproyl)-2-deoxy-beta-d-glucopyranosylamine

C14H27N3O6 (333.1899762)


   

(2S,3R)-1-Benzyl 3-tert-butyl 2-methylpiperidine-1,3-dicarboxylate

(2S,3R)-1-Benzyl 3-tert-butyl 2-methylpiperidine-1,3-dicarboxylate

C19H27NO4 (333.1939982)


   

1-[(TERT-BUTYL)OXYCARBONYL]-3-(4-METHYLBENZYL)PIPERIDINE-3-CARBOXYLIC ACID

1-[(TERT-BUTYL)OXYCARBONYL]-3-(4-METHYLBENZYL)PIPERIDINE-3-CARBOXYLIC ACID

C19H27NO4 (333.1939982)


   

Ethyl cis-N-Boc-3-phenylpiperidine-4-carboxylate

Ethyl cis-N-Boc-3-phenylpiperidine-4-carboxylate

C19H27NO4 (333.1939982)


   

1-Benzyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-indole

1-Benzyl-5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-1H-indole

C21H24BNO2 (333.1899994)


   
   

BENZYL (+/-)-TRANS-N-BOC-4-METHYL-PIPERIDINE-2-CARBOXYLATE

BENZYL (+/-)-TRANS-N-BOC-4-METHYL-PIPERIDINE-2-CARBOXYLATE

C19H27NO4 (333.1939982)


   

1-Benzyl 3-ethyl 3-isopropyl-1,3-piperidinedicarboxylate

1-Benzyl 3-ethyl 3-isopropyl-1,3-piperidinedicarboxylate

C19H27NO4 (333.1939982)


   

benzhydrylboronic acid,4-propan-2-ylpyridine

benzhydrylboronic acid,4-propan-2-ylpyridine

C21H24BNO2 (333.1899994)


   

1-Azepanyl-[2-(phenylmethyl)-1-benzimidazolyl]methanone

1-Azepanyl-[2-(phenylmethyl)-1-benzimidazolyl]methanone

C21H23N3O (333.1841028)


   

1-(3,5-Dimethylphenyl)-4-(1-ethyl-2-benzimidazolyl)-2-pyrrolidinone

1-(3,5-Dimethylphenyl)-4-(1-ethyl-2-benzimidazolyl)-2-pyrrolidinone

C21H23N3O (333.1841028)


   

(1S,9S,10S,13R)-3,4-Dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-10,13-diol

(1S,9S,10S,13R)-3,4-Dimethoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-10,13-diol

C19H27NO4 (333.1939982)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics

   

4-Hydroxyoctanedioylcarnitine

4-Hydroxyoctanedioylcarnitine

C15H27NO7 (333.1787432)


   

3-Hydroxyoctanedioylcarnitine

3-Hydroxyoctanedioylcarnitine

C15H27NO7 (333.1787432)


   

6-(2-Hydroxyethoxy)-6-oxohexanoylcarnitine

6-(2-Hydroxyethoxy)-6-oxohexanoylcarnitine

C15H27NO7 (333.1787432)


   

2,2-dimethyl-N-[[2-(4-methyl-1-piperidinyl)anilino]-sulfanylidenemethyl]propanamide

2,2-dimethyl-N-[[2-(4-methyl-1-piperidinyl)anilino]-sulfanylidenemethyl]propanamide

C18H27N3OS (333.1874732)


   
   
   
   
   
   
   

(3R,9R)-9-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydecanoate

(3R,9R)-9-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydecanoate

C16H29O7- (333.1913184)


   

(3R)-10-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydecanoate

(3R)-10-[(2R,3R,5R,6S)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-3-hydroxydecanoate

C16H29O7- (333.1913184)


   

4-(3-Acetyloxy-2-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

4-(3-Acetyloxy-2-propanoyloxypropoxy)-2-(trimethylazaniumyl)butanoate

C15H27NO7 (333.1787432)


   

bhos#16(1-)

bhos#16(1-)

C16H29O7 (333.1913184)


Conjugate base of bhos#16

   

bhas#16(1-)

bhas#16(1-)

C16H29O7 (333.1913184)


Conjugate base of bhas#16

   

6-hydroxy-6-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3-methyl-1-(1h-pyrrol-2-yl)hexa-2,4-dien-1-one

6-hydroxy-6-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3-methyl-1-(1h-pyrrol-2-yl)hexa-2,4-dien-1-one

C19H27NO4 (333.1939982)


   

(2z)-2-[(1-hydroxydecylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

(2z)-2-[(1-hydroxydecylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

C19H27NO4 (333.1939982)


   

(1s,4s,5s,6s,9s)-6-methyl-2,8-dioxo-13-azatetracyclo[11.3.1.0¹,⁹.0⁴,⁹]heptadecan-5-yl acetate

(1s,4s,5s,6s,9s)-6-methyl-2,8-dioxo-13-azatetracyclo[11.3.1.0¹,⁹.0⁴,⁹]heptadecan-5-yl acetate

C19H27NO4 (333.1939982)


   

3-{[(1r,2r,4as,8ar)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl](hydroxy)methylidene}-5-(1-hydroxyethyl)-1-methylpyrrolidine-2,4-dione

3-{[(1r,2r,4as,8ar)-2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl](hydroxy)methylidene}-5-(1-hydroxyethyl)-1-methylpyrrolidine-2,4-dione

C19H27NO4 (333.1939982)


   

3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),8'(12'),9'-triene-4,11'-diol

3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),8'(12'),9'-triene-4,11'-diol

C19H27NO4 (333.1939982)


   

(1h-indol-3-ylmethyl)[2-(5-methoxy-1h-indol-3-yl)ethyl]methylamine

(1h-indol-3-ylmethyl)[2-(5-methoxy-1h-indol-3-yl)ethyl]methylamine

C21H23N3O (333.1841028)


   

(2z,4e)-6-hydroxy-6-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3-methyl-1-(1h-pyrrol-2-yl)hexa-2,4-dien-1-one

(2z,4e)-6-hydroxy-6-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-3-methyl-1-(1h-pyrrol-2-yl)hexa-2,4-dien-1-one

C19H27NO4 (333.1939982)


   

(1r,3r,4r,4's)-3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),8'(12'),9'-triene-4,11'-diol

(1r,3r,4r,4's)-3,10'-dimethoxy-5'-methyl-5'-azaspiro[cyclohexane-1,2'-tricyclo[6.3.1.0⁴,¹²]dodecane]-1'(11'),8'(12'),9'-triene-4,11'-diol

C19H27NO4 (333.1939982)


   

n-{2-[1-(3,4-dimethoxyphenyl)-4-oxocyclohexyl]ethyl}-n-methylacetamide

n-{2-[1-(3,4-dimethoxyphenyl)-4-oxocyclohexyl]ethyl}-n-methylacetamide

C19H27NO4 (333.1939982)


   

4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-triene-5,12-diol

4,13-dimethoxy-17-methyl-17-azatetracyclo[7.5.3.0¹,¹⁰.0²,⁷]heptadeca-2(7),3,5-triene-5,12-diol

C19H27NO4 (333.1939982)


   

6,7,11-trihydroxy-3,7,11-trimethyl-1-(1h-pyrrol-2-yl)dodeca-2,4,9-trien-1-one

6,7,11-trihydroxy-3,7,11-trimethyl-1-(1h-pyrrol-2-yl)dodeca-2,4,9-trien-1-one

C19H27NO4 (333.1939982)


   

3-[hydroxy(2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)methylidene]-5-(1-hydroxyethyl)-1-methylpyrrolidine-2,4-dione

3-[hydroxy(2-methyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl)methylidene]-5-(1-hydroxyethyl)-1-methylpyrrolidine-2,4-dione

C19H27NO4 (333.1939982)


   

2-[(1-hydroxydecylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

2-[(1-hydroxydecylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

C19H27NO4 (333.1939982)


   

(2z)-2-[(1-hydroxy-8-methylnonylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

(2z)-2-[(1-hydroxy-8-methylnonylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

C19H27NO4 (333.1939982)


   

(2z,4e,9e)-6,7,11-trihydroxy-3,7,11-trimethyl-1-(1h-pyrrol-2-yl)dodeca-2,4,9-trien-1-one

(2z,4e,9e)-6,7,11-trihydroxy-3,7,11-trimethyl-1-(1h-pyrrol-2-yl)dodeca-2,4,9-trien-1-one

C19H27NO4 (333.1939982)


   

2-[(1-hydroxy-8-methylnonylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

2-[(1-hydroxy-8-methylnonylidene)amino]-3-(4-hydroxyphenyl)prop-2-enoic acid

C19H27NO4 (333.1939982)